Format

Send to

Choose Destination
J Clin Epidemiol. 2013 Aug;66(8 Suppl):S130-7. doi: 10.1016/j.jclinepi.2013.02.015.

Bayesian adaptive trials offer advantages in comparative effectiveness trials: an example in status epilepticus.

Author information

1
Berry Consultants, 4301 Westbank Dr, Suite 140, Bldg B, Austin, TX 78746, USA. jason@berryconsultants.com

Abstract

OBJECTIVE:

We present a novel Bayesian adaptive comparative effectiveness trial comparing three treatments for status epilepticus that uses adaptive randomization with potential early stopping.

STUDY DESIGN AND SETTING:

The trial will enroll 720 unique patients in emergency departments and uses a Bayesian adaptive design.

RESULTS:

The trial design is compared to a trial without adaptive randomization and produces an efficient trial in which a higher proportion of patients are likely to be randomized to the most effective treatment arm while generally using fewer total patients and offers higher power than an analogous trial with fixed randomization when identifying a superior treatment.

CONCLUSION:

When one treatment is superior to the other two, the trial design provides better patient care, higher power, and a lower expected sample size.

KEYWORDS:

Adaptive sample size; Bayesian adaptive trials; Comparative effectiveness research; Emergency medicine; Response adaptive randomization; Status epilepticus

PMID:
23849147
PMCID:
PMC3743558
DOI:
10.1016/j.jclinepi.2013.02.015
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center